Peter T. Nieh - Concepedia

Author

Peter T. Nieh

Emory University

Also Known As

JohnG Pattaras, P Nieh, P. Nieh, P.T. Nieh, PETER T. NIEH, Peter Nieh, Peter T Nieh, Peter T. Nieh

124

Publications

3.1K

Citations

H-Index

Concepts

All Affiliations

Emory University Lahey Hospital and Medical Center Emory University Hospital Georgia Institute of Technology Harvard University

About

Peter T. Nieh is an author at Emory University specializing in urology, medicine, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	20	893
2	Health Sciences	8	8	676
3	Engineering	6	6	390
4	Biomedical Engineering	2	2	278
5	Public Health	1	1	10

Peter T. Nieh

Publications

2.8K

Citations

H-Index

Page 1

	Year	Citations
Initial experience with the radiotracer anti-1-amino-3-18F-fluorocyclobutane-1-carboxylic acid with PET/CT in prostate carcinoma. David M. Schuster, John R. Votaw, Peter T. Nieh, PubMed	2007	275
Hyperspectral imaging and quantitative analysis for prostate cancer detection Hamed Akbari, Luma V. Halig, David M. Schuster, Journal of Biomedical Optics UrologyImage AnalysisHyperspectral DataMedical ImagingEngineering	2012	263
Multisite Experience of the Safety, Detection Rate and Diagnostic Performance of Fluciclovine ( <sup>18</sup> F) Positron Emission Tomography/Computerized Tomography Imaging in the Staging of Biochemically Recurrent Prostate Cancer Tore Bach‐Gansmo, Cristina Nanni, Peter T. Nieh, The Journal of Urology	2016	176
Anti-3-[ <sup>18</sup> F]FACBC Positron Emission Tomography-Computerized Tomography and <sup>111</sup> In-Capromab Pendetide Single Photon Emission Computerized Tomography-Computerized Tomography for Recurrent Prostate Carcinoma: Results of a Prospective Clinical Trial David M. Schuster, Peter T. Nieh, Ashesh B. Jani, The Journal of Urology	2013	171
Detection of Recurrent Prostate Carcinoma with<i>anti</i>-1-Amino-3-<sup>18</sup>F-Fluorocyclobutane-1-Carboxylic Acid PET/CT and<sup>111</sup>In–Capromab Pendetide SPECT/CT David M. Schuster, Bital Savir-Baruch, Peter T. Nieh, Radiology	2011	149
Recurrent prostate cancer detection with anti-3-[18F]FACBC PET/CT: comparison with CT Oluwaseun Odewole, Funmilayo Tade, Peter T. Nieh, European Journal of Nuclear Medicine and Molecular Imaging Positron Emission TomographyUrologyOncologic ImagingMedical ImagingMedicine	2016	147
Prostate Specific Antigen Decreases After Withdrawal of Antiandrogen Therapy with Bicalutamide or Flutamide in Patients Receiving Combined Androgen Blockade Paul F. Schellhammer, Peter Venner, Gabriel P. Haas, The Journal of Urology	1997	99
Change in Salvage Radiotherapy Management Based on Guidance With FACBC (Fluciclovine) PET/CT in Postprostatectomy Recurrent Prostate Cancer Oladunni Akin-Akintayo, Ashesh B. Jani, Oluwaseun Odewole, Clinical Nuclear Medicine	2016	80
Characterization of primary prostate carcinoma by anti-1-amino-2-[(18)F] -fluorocyclobutane-1-carboxylic acid (anti-3-[(18)F] FACBC) uptake. David M. Schuster, Pooneh Alaei Taleghani, Peter T. Nieh, PubMed Surgical OncologyOncologic ImagingPet-mriTumor BiologyPositron Emission Tomography	2013	79
Absolute Preoperative C-Reactive Protein Predicts Metastasis and Mortality in the First Year Following Potentially Curative Nephrectomy for Clear Cell Renal Cell Carcinoma T. Johnson, Amin Abbasi, Ashli Owen‐Smith, The Journal of Urology	2009	77

Page 1